GeneDx Holdings Corp. (WGS) — Capital Reinvestment Ratio
GeneDx Holdings Corp. (WGS) has a Capital Reinvestment Ratio of 0.39x as of September 2025, meaning it reinvests 0% of its operating cash flow ($15.77 Million) in capital expenditures ($6.17 Million). See GeneDx Holdings Corp. (WGS) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
GeneDx Holdings Corp. Capital Reinvestment Ratio (2025–2025)
This chart tracks GeneDx Holdings Corp.'s Capital Reinvestment Ratio across 1 annual periods. Check how aggressively does GeneDx Holdings Corp. reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for GeneDx Holdings Corp. (2025–2025)
Year-by-year Capital Reinvestment Ratio for GeneDx Holdings Corp. from 2025 to 2025. For live market cap and broader valuation context, see WGS market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.57x | $33.28 Million | $19.02 Million | — |